跳至主要内容
临床试验/NCT00152620
NCT00152620终止不适用

Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease

University of Chicago2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2004年6月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
40
试验地点
2
主要终点
Pediatric Crohn's Disease Activity Index (PCDAI)

研究概览

简要总结

The aim of this therapeutic trial is to compare the response of subjects with active IBD to daily intravenous dexamethasone versus the response to daily intravenous methylprednisolone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double

入排标准

年龄范围
6 Years 至 19 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Parental informed consent
  • Subjects 6 to 19 years of age with confirmed diagnosis of IBD (Crohn's disease, ulcerative colitis or indeterminate colitis), who on admission to the hospital have a PCDAI>15 or a Clinical-Activity Index for the Evaluation of Patients with Ulcerative Colitis of >
  • Infectious causes (viruses, bacteria, parasites) have been ruled out.

排除标准

  • Subjects in which the administration of corticosteroids would be contraindicated such as systemic or enteric infections diagnosed by stool analysis including culture, Clostridium Difficile toxin assay, rotavirus or adenovirus 40/41 antigens.
  • Subjects with enterostomy or colostomy
  • Subjects with one or more of the following conditions: unstable vital signs, acute abdomen, toxic megacolon, intestinal obstruction, intestinal perforation

结局指标

主要结局

Pediatric Crohn's Disease Activity Index (PCDAI)

Clinical-Activity Index for the Evaluation of Patients with Ulcerative Colitis

次要结局

  • Partial Harvey Bradshaw score (pHB)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验